NEO-PEARL Scoping Review: Scoping review of pharmacological symptom management in neonatal palliative and end-of-life care

Read full text Summarise with VIRAT
Authors: Lynda Ann Brook
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The NEO‑PEARL Scoping Review forms a central component of a wider programme aiming to strengthen the evidence base for safe, effective pharmacological symptom management in neonatal palliative and end‑of‑life care. Neonates experience high mortality and significant symptom burden, yet clinical decision‑making is often constrained by limited neonatal‑specific data on dosing, non‑enteral routes, formulation safety, and practical feasibility. Evidence is dispersed, heterogeneous, and frequently extrapolated from older populations. This review will systematically map what is known about symptoms and sources of suffering in neonates up to four weeks corrected gestational age receiving palliative and end-of-life care, and how these are managed pharmacologically across settings including NICU, hospice, and community care. Using PRISMA‑ScR–aligned methods, a comprehensive database search will identify studies of any design reporting relevant symptoms, medicines, doses, routes, formulations, excipients, outcomes, and feasibility notes. Dual screening and structured data charting will ensure consistent inclusion. Findings will be synthesised descriptively and thematically to identify patterns, variations in practice, and gaps in neonatal‑specific evidence. The expected outcomes are a detailed summary of the available research evidence, highlighting current practices, areas of variation, and important gaps in neonatal‑specific data. This will clarify where further investigation, dosing guidance, and formulation development are most urgently needed. The findings will directly inform the NEO‑PEARL Delphi consensus process and support the development of future clinical recommendations.

Fields of Study & Subjects

Palliative Care and End-of-Life Issues Palliative and Oncologic Care Pharmaceutical studies and practices

Publication details

Journal / source
Open Science Framework
Publication date
1 January 2026
Language
EN